Daré Bioscience Inc.

NASDAQ: DARE · Real-Time Price · USD
2.06
0.04 (1.98%)
At close: Aug 20, 2025, 3:59 PM
2.03
-1.55%
After-hours: Aug 20, 2025, 06:44 PM EDT

Daré Bioscience Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-4.02M -4.38M -5.51M -4.7M -6.76M -6.76M -5.06M -8.3M -8.76M -8.04M -15.94M -7.02M 414K -8.4M -9.54M -12.67M -9.16M -7.32M
Depreciation & Amortization
460.07K 158.11K 6.37K 9.74K 10.78K 10.78K 9.98K 9.26K 9.62K 9.51K 10.62K 3.03K 5.32K 5.23K 7.05K 6.34K 6.61K 6.41K
Stock-Based Compensation
359.02K 377.36K 489.26K 466.5K 627.7K 627.7K 619.79K 636.09K 650.19K 624.62K 532.13K 556.45K 537.52K 532.41K 388.81K 439.5K 405.48K 365.91K
Other Working Capital
-2.27M -1.85M 9.3M -1.31M -1.72M -1.72M -2.43M 1.04M -2.32M -8.77M 10.96M 12.72M -7.71M -5.2M -2.24M 13.13M -1.76M -1.48M
Other Non-Cash Items
255.74K 128.3K 245.84K 219.21K 1.23M 802.67K 2.16M 198.41K -5.91K 89.94K -5.91K -27.1K 19.7K -9.76K -26.78K 20.2K -21.05K -24.22K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -2.06M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -369.89K
Change in Working Capital
-2.48M -1.76M 9.99M -1.92M -1.51M -1.5M -3.85M -518.5K 1.52M -8.8M 9.51M 15.09M -9.43M -4.47M -742.7K 13.52M -3.02M -1.03M
Operating Cash Flow
-5.42M -5.47M 5.23M -5.92M -6.82M -6.81M -8.18M -7.97M -6.59M -16.12M -5.9M 8.6M -8.45M -12.34M -9.92M 1.32M -11.79M -8.38M
Capital Expenditures
153.4K -157.33K -562.85K 282.32K -7.3K -7.3K -607.33K -22.1K n/a n/a -2.7K -55K -816 -4.55K -14.52M -14.52K n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 925M n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -924.99M n/a n/a n/a
Investing Cash Flow
153.4K -157.33K -562.85K 282.32K -7.3K -7.3K -607.33K -22.1K n/a n/a -2.7K -55K -816 -4.55K -14.51M -14.52K n/a n/a
Debt Repayment
-521.26K -187.22K -187.22K 436.85K -200.39K -200.39K -200.39K 467.58K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
2.45K -2.45K -279 -405 -690 -690 4.72M n/a n/a 1.3M n/a 4.46K 120.15K n/a 277.81K 204.47K n/a 50.4K
Financial Cash Flow
-43.79K 246.58K -132.01K 436.44K 21.71K 14.03K 5.31M 8.58M 452.19K 1.3M n/a 4.46K 1.34M n/a 16M 35.22M 13.25M 11.37M
Net Cash Flow
-5.29M -5.37M 4.47M -5.18M -6.85M -6.85M -3.42M 565.32K -6.17M -14.84M -5.72M 8.32M -7.25M -12.36M 6.1M 36.46M 1.45M 2.99M
Free Cash Flow
-5.26M -5.63M 4.66M -5.64M -6.83M -6.82M -8.79M -8M -6.59M -16.12M -5.9M 8.55M -8.45M -12.35M -24.44M 1.31M -11.79M -8.38M